Oral morphine for cancer pain (Q24185873)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article (publication date: 22 April 2016)

Language	Label	Description	Also known as
English	Oral morphine for cancer pain	scientific article (publication date: 22 April 2016)

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

Oral morphine for cancer pain (English)

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Philip J Wiffen

1

0 references

Robert Andrew Moore

3

object named as

R Andrew Moore

0 references

author name string

Bee Wee

2

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

publication date

22 April 2016

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

Cochrane Database of Systematic Reviews

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

4

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

CD003868

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Controlled release morphine tablets: a double-blind trial in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Intravenous morphine for rapid control of severe cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Controlled-release oxycodone and morphine in cancer related pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Morphine or oxycodone in cancer pain?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A comparative study of 2 sustained-release morphine preparations for pain in advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Controlled-release morphine in cancer pain. Is a loading dose required when the formulation is changed?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Morphine and oxycodone hydrochloride in the management of cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, explorat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

An assessment of the efficacy and tolerability of a 'double dose' of normal-release morphine sulphate at bedtime

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Choice of strong analgesic in terminal cancer: diamorphine or morphine?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Opioid treatment for radiating cancer pain: oral administration vs. epidural techniques

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A randomized study on oral administration of morphine and methadone in the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Clinical observations on controlled-release morphine in cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Comparisons of the Analgesic Effects of Oral and Intramuscular Oxymorphone and of Intramuscular Oxymorphone and Morphine in Patients with Cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: Results of a double blind randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Long-term treatment of cancer pain with transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A novel morphine sulphate preparation: clinical trial of a controlled-release morphine suspension in cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Dose-ranging study of oxycodone for chronic pain in advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Self-administration of morphine in bone marrow transplant patients reduces drug requirement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Patient-controlled analgesic infusions: alfentanil versus morphine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Cocaine and morphine interaction in acute and chronic cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A multi-investigator clinical evaluation of oral controlled-release morphine (MS Contin tablets) administered to cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Use of strong opioids in advanced cancer pain: a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Management of cancer pain with oral controlled-release morphine sulfate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Randomised trial of oral morphine for chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Octreotide: a potent new non-opiate analgesic for intrathecal infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Peak plasma concentrations after oral morphine: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Systematic review of factors affecting the ratios of morphine and its major metabolites

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Transdermal fentanyl for cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Meta-analysis in clinical research

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Amitriptyline for neuropathic pain and fibromyalgia in adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Expect analgesic failure; pursue analgesic success

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Hydromorphone for acute and chronic pain.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

Oxycodone for cancer-related pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003868.PUB4

21 January 2018

The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cervical versus thoracic epidural morphine for the treatment of head and neck cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative analgesic potency of intramuscular heroin and morphine in cancer patients with postoperative pain: a preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecal morphine for postoperative pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of two novel rectal controlled-release morphine formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tramadol and the possibilities for its use with cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, crossover trial of intravenous clodronate in metastatic bone pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphine at gramme doses: kinetics, dynamics and clinical need

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An exploratory analysis on the effectiveness of four strong opioids in patients with cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphine as the first drug for the treatment of cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose epidural opioid treatment of malignant pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe cancer pain by low-dose continuous subcutaneous morphine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Morphine depot tablets compared with conventional morphine tablets in the treatment of cancer pain]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of severe pain with sustained-release morphine tablets v. oral morphine solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles of cancer pain management. Use of long-acting oral morphine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of controlled-released morphine on quality of life for cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rescue factor: A design for evaluating long-acting analgesics

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Brompton mixture versus morphine solution given orally: effects on pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analgesia with oral narcotics and added ibuprofen in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral fenoprofen compared to intramuscular morphine and oral aspirin in cancer patients with postoperative pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of pain in terminal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady-state kinetics and analgesic effect of oral morphine in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative analgesic potency of oral zomepirac and intramuscular morphine in cancer patients with postoperative pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of morphine and ketorolac for intravenous patient-controlled analgesia in postoperative cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphine pharmacokinetics and effects on salivation and continuous reaction times in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral morphine on cold pressor tolerance time and neuropsychological performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developing a database of published reports of randomised clinical trials in pain research

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Preventive analgesic effect of intraoperative administration of ibuprofen-arginine on postmastectomy pain syndrome]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Pharmacodynamic Study of Morphine and Its Glucuronide Metabolites After Single Morphine Dosing in Cancer Patients with Pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dextropropoxyphene versus morphine in Opioid-Naive cancer patients with pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL® capsules) with MST Continus® tablets in cancer patients with severe pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/27105021

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/14651858.CD003868.PUB4

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

30 June 2019

http://europepmc.org/abstract/PMC/6540940

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24185873&oldid=1544058337"